Why is Nath Bio-Genes falling/rising?

As of 08-Jul, Nath Bio-Genes (India) Ltd is experiencing a price increase, currently at Rs 228.40, which reflects a rise of Rs 5.9 or 2.65%. The stock has shown a strong performance recently, gaining 9.97% over the last four days and outperforming the sector, although it underperformed the sector today by 0.86%. It has also been trading above its moving averages across various time frames. Despite a negative return of -10.08% over the past year, the stock's valuation appears attractive with a Price to Book Value of 0.7, and it is trading at a discount compared to its peers. However, the company has faced challenges with declining profits and negative results over the last three quarters, which may temper investor enthusiasm.
In the broader market context, Nath Bio-Genes has outperformed the Sensex in the short term, with a 1-week return of +9.65% compared to the benchmark's negligible increase of +0.02%. While the stock has shown positive momentum recently, its long-term fundamentals remain weak, with a low Return on Capital Employed (ROCE) of 7.19% and consistent underperformance against benchmarks over the last three years. The agricultural sector has gained overall, contributing to the stock's recent rise, but the company's ongoing financial struggles and declining profitability could pose risks to sustained growth.